Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

1.

Mild stimulation in in vitro fertilization.

Macklon NS, Fauser BC.

Ann N Y Acad Sci. 2003 Nov;997:105-11. Review.

PMID:
14644815
2.

[Evolution of ovarian stimulation in in vitro fertilization].

Delbaere A, Devreker F, Hannes M, Koenig I, Holoye A, Englert Y.

Rev Med Brux. 1999 Oct;20(5):A446-52. Review. French.

PMID:
10582480
3.

The ISMAAR proposal on terminology for ovarian stimulation for IVF.

Nargund G, Fauser BC, Macklon NS, Ombelet W, Nygren K, Frydman R; Rotterdam ISMAAR Consensus Group on Terminology for Ovarian Stimulation for IVF.

Hum Reprod. 2007 Nov;22(11):2801-4. Epub 2007 Sep 12.

PMID:
17855409
4.
5.

GnRH antagonists in ovarian stimulation for IVF.

Tarlatzis BC, Fauser BC, Kolibianakis EM, Diedrich K, Rombauts L, Devroey P.

Hum Reprod Update. 2006 Jul-Aug;12(4):333-40. Epub 2006 Mar 27. Review. Erratum in: Hum Reprod Update. 2006 Nov-Dec;12(6):797. Rombauts, L [added].

PMID:
16567347
7.

Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.

Moon HS, Joo BS, Moon SE, Lee SK, Kim KS, Koo JS.

Fertil Steril. 2008 Dec;90(6):2172-8. doi: 10.1016/j.fertnstert.2007.10.033. Epub 2008 Apr 25.

PMID:
18439601
8.

GnRH antagonists in IVF.

Kolibianakis EM, Tarlatzis B, Devroey P.

Reprod Biomed Online. 2005 Jun;10(6):705-12. Review. Erratum in: Reprod Biomed Online. 2005 Aug;11(2):271.

PMID:
15969996
9.

GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis.

Griesinger G, Diedrich K, Devroey P, Kolibianakis EM.

Hum Reprod Update. 2006 Mar-Apr;12(2):159-68. Epub 2005 Oct 27. Review.

PMID:
16254001
10.

Fewer medications for in vitro fertilization can be better: thinking outside the box.

Muasher SJ, Garcia JE.

Fertil Steril. 2009 Oct;92(4):1187-9. doi: 10.1016/j.fertnstert.2009.05.053. Epub 2009 Jun 27.

PMID:
19560756
11.

Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.

Cheon KW, Byun HK, Yang KM, Song IO, Choi KH, Yoo KJ.

J Reprod Med. 2004 Sep;49(9):733-8.

PMID:
15493565
12.

Adding human menopausal gonadotrophin to antagonist protocols - is there a benefit?

Martin-Johnston M, Beltsos AN, Grotjan HE, Uhler ML.

Reprod Biomed Online. 2007 Aug;15(2):161-8.

PMID:
17697491
13.

Cumulative pregnancy rates after three cycles of minimal stimulation IVF and results according to subfertility diagnosis: a multicentre cohort study.

Pelinck MJ, Vogel NE, Hoek A, Simons AH, Arts EG, Mochtar MH, Beemsterboer S, Hondelink MN, Heineman MJ.

Hum Reprod. 2006 Sep;21(9):2375-83. Epub 2006 Jun 3.

PMID:
16751647
14.

Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function.

Barad DH, Weghofer A, Gleicher N.

Obstet Gynecol. 2007 Jun;109(6):1404-10.

PMID:
17540814
15.

Mild/minimal stimulation for in vitro fertilization: an old idea that needs to be revisited.

Zarek SM, Muasher SJ.

Fertil Steril. 2011 Jun 30;95(8):2449-55. doi: 10.1016/j.fertnstert.2011.04.041. Epub 2011 May 7. Review.

PMID:
21550037
16.

GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS.

Engmann L, Siano L, Schmidt D, Nulsen J, Maier D, Benadiva C.

Reprod Biomed Online. 2006 Nov;13(5):639-44.

PMID:
17169172
17.

[Biological assessment criteria during antagonist protocols].

Plachot M.

J Gynecol Obstet Biol Reprod (Paris). 2004 Oct;33(6 Pt 2):3S32-5. French.

PMID:
15643685
18.

Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET.

Drakakis P, Loutradis D, Kallianidis K, Liapi A, Milingos S, Makrigiannakis A, Dionyssiou-Asteriou A, Michalas S.

Eur J Obstet Gynecol Reprod Biol. 2005 Jul 1;121(1):77-80.

PMID:
15989987
19.

The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis.

Verberg MF, Eijkemans MJ, Macklon NS, Heijnen EM, Baart EB, Hohmann FP, Fauser BC, Broekmans FJ.

Hum Reprod Update. 2009 Jan-Feb;15(1):5-12. doi: 10.1093/humupd/dmn053. Review.

PMID:
19091754
20.

GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.

Humaidan P, Bredkjaer HE, Bungum L, Bungum M, Gr√łndahl ML, Westergaard L, Andersen CY.

Hum Reprod. 2005 May;20(5):1213-20. Epub 2005 Mar 10.

PMID:
15760966

Supplemental Content

Support Center